To study jointly success and treatment discontinuation in IVF programs, a shared random effects model was built and used to analyze data from two French IVF centers: a Parisian center and a medium-sized city center. We found no evidence of a link between success and discontinuation processes in the Parisian center, whereas we did find one in the medium-sized city center. In the medium-sized city center, the negative link observed between the two processes meant that women who discontinued treatment in this center had a lower probability of success. The direction of the link was expected and is in agreement with the literature, as previous studies have reported poorer prognostic factors of IVF success among women who discontinued treatment [
1,
4,
10]. However, it is interesting that no evidence of such a link was observed in the Parisian center.
Woman’s age: effect on success and treatment discontinuation
By defining success as a live birth during the entire IVF program (first to fourth IVF attempts), we demonstrated an inverse-J relationship between the woman’s age and success. Such a relationship has already been shown [
21]. We also found that the probability of discontinuation varied inversely to the probability of success according to the woman’s age, and that the probability of discontinuation globally increased with increasing female age. In our study, using women aged 30-34 years as reference, OR of treatment discontinuation was 2.9 ([2.2-3.7]) for women older than 40 years. A few studies have already shown that women who discontinued treatment were generally older that women who persevered [
22]. In our study, we assessed how the cumulative risk of discontinuation alters with the woman’s age and we demonstrated a J-relationship between the woman’s age and cumulative risk of discontinuation during an IVF program.
IVF center: variability in success and treatment discontinuation
In our study, the crude cumulative success rate differed according to center (34% vs 41%), but after controlling for treatment discontinuation and the woman’s age, the probability of success no longer differed between centers (Figure
2). This result is similar to that of a study carried out in two centers in the Netherlands [
23]. Investigators found that the crude cumulative live birth rates differed between the two centers. However, this difference was not due to differences in success rates at each attempt, but rather to different discontinuation rates in each center. These observations showed that comparison of IVF centers should not be done on crude success rate and that treatment discontinuation is an important factor that should be taken into account.
Conversely, we found that treatment discontinuation rates differed between centers, being lower in the medium-sized city center. Moreover, a negative link was found between success and discontinuation in the medium-sized city center, whereas there was no evidence of such a link in the Parisian center. One explanation could be that the characteristics of women who discontinued treatment differed between the two centers. In the medium-sized city center, the negative link meant that women who discontinued had poorer prognostic factors. In the Parisian center, there was no reason why women with poorer prognostic factors did not discontinue treatment, but the higher level of discontinuation could indicate that women with good prognostic factors also discontinued IVF treatment in the Parisian center. This hypothesis of a more mixed population could explain the lack of significant link between success and discontinuation in the Parisian center. Differences between fertility centers may be linked to various factors such as patient selection, medical staff, or management practices (i.e. choice of IVF vs ICSI, number of embryos transferred). However, one major difference between the two centers in our study is their geographical environment: the Parisian center is surrounded by 23 other IVF centers (9 in Paris itself and 14 in the suburbs), whereas the medium-sized city center is the only one in this administrative area and the nearest other center is in the city of Lyon, a 2-hour drive away. Consequently, the medium-sized city center could be defined as a monopoly center, whereas the Parisian one competes with several other fertility centers. When there are several fertility centers close to the woman’s place of residence (a competition situation between centers), the population of women who discontinue is probably mixed, consisting of both patients with a poorer prognosis and patients who merely change IVF center, whatever their prognosis. On the contrary, in a monopoly center, as women cannot easily discontinue in order to begin another IVF program elsewhere, most treatment discontinuations are linked to poorer prognostic factors.
To the best of our knowledge, this is the first time that the hypothesis of an association between treatment discontinuation and a monopoly/competition situation of the IVF center has emerged in the literature. However, an association between success and a monopoly situation or competition between IVF centers has already been considered. Indeed, some studies have tested the association between an increasing number of multiple pregnancies and competition between IVF centers, the underlying hypothesis being that a greater number of embryos are transferred in centers that compete against various others, in order to maximize the chance of success [
24,
25]. Recently, a large American study, conducted in clinics performing ART between 1995 and 2001 (
n = 2374 clinic-years), has examined the relationship between competition and clinic-level ART outcomes and practice patterns [
26]. Defining competition as the number of clinics within a 20-mile radius (32.19 km) of a given clinic, they found no evidence of a significant relationship between competition and birth rates in multivariate models. Moreover, they found a lower, rather than a higher, rate of multiple births per ART cycle for clinics in highly competitive areas, as has been suggested in one previous study using another definition for competition [
27]. Our results are in agreement with the American study, showing no difference between the two centers, one being in a monopoly situation and the other in a competition situation, with regard to chance of success.
Study limitations
In our model, we included only female age and center as fixed effects. In the context of growing interest in understanding differences between IVF success rates according to center [
28,
29], some studies have explored to what extent such differences may be linked to differences in patients’ characteristics. An English study has explored the influence of patients’ characteristics on live birth rate per cycle started [
30]. The authors demonstrated the impact of non-IVF related patient characteristics on the success rate and concluded that using a “standard patient group and outcome” did not improve validity of comparisons between centers. More recently, using IVF and ICSI treatment data from 11 IVF centers in the Netherlands, Lintsen et al. studied how differences in IVF success rates between centers could be explained by patient characteristics and concluded that only 17% of the variation between centers could be explained by patient mix [
31]. Thus, there is currently no clear evidence that other patient characteristics should be taken into account in our multivariate model. However, our shared random effects model could be extended by including temporal effects that could describe, for instance, the patient’s level of discouragement due to psychological and physical burden. Such a temporal effect could also be included in the model to test if the link between the success and treatment discontinuation processes may also depend on the IVF attempt. Obviously, it would be of great interest to conduct such analysis on a greater number of centers to better understand how the center’s situation impacts on treatment discontinuation.
Study implications
Despite the increasing interest in understanding differences in IVF success rates between IVF centers, the reasons explaining such differences remain rather unclear. It is likely that differences in IVF centers success rates are a combination of patient and center characteristics [
32]. Treatment discontinuation rate could be one of the factors impacting on the center success rate but it has scarcely been investigated. In our study, we observed two French centers with different crude success rates. After controlling for the woman’s age and for the impact of discontinuation on success rate in a shared random effects model, success rates between the two centers no longer differed. Our results showed that discontinuation may be a very important factor in explaining success rate differences between centers, and it needs to be better understood.
Our study also enabled us to explore treatment discontinuation. Our main result was that discontinuation appeared very dissimilar in the two centers. The center strongly influenced the risk of treatment discontinuation (unlike the chance of success). An important perspective of this work will be to explore further the discontinuation process and differences between centers in a larger number of centers. Based on our results, a very promising hypothesis would be to explore the possible influence of the IVF center situation (monopoly/non-monopoly) on the probability of treatment discontinuation. Our hypothesis is that the probability of treatment discontinuation decreased in centers that were in a monopoly situation.